M
Michael Stowasser
Researcher at University of Queensland
Publications - 293
Citations - 15529
Michael Stowasser is an academic researcher from University of Queensland. The author has contributed to research in topics: Primary aldosteronism & Aldosterone. The author has an hindex of 57, co-authored 273 publications receiving 13359 citations. Previous affiliations of Michael Stowasser include Translational Research Institute & Princess Alexandra Hospital.
Papers
More filters
Journal ArticleDOI
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline
John W. Funder,Robert M. Carey,Franco Mantero,M. Hassan Murad,Martin Reincke,Hirotaka Shibata,Michael Stowasser,William F. Young +7 more
TL;DR: This guideline recommends that all patients with primary aldosteronism undergo adrenal computed tomography as the initial study in subtype testing and to exclude adrenocortical carcinoma and advises that an experienced radiologist should establish/exclude unilateral primary aldehydes using bilateral adrenal venous sampling.
Journal ArticleDOI
Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism : An Endocrine Society Clinical Practice Guideline
John W. Funder,Robert M. Carey,Carlos E. Fardella,Celso E. Gomez-Sanchez,Franco Mantero,Michael Stowasser,William F. Young,Victor M. Montori +7 more
TL;DR: The Task Force developed clinical practice guidelines for the diagnosis and treatment of patients with primary aldosteronism and recommended that patients with bilateral adrenal hyperplasia, or those unsuitable for surgery, optimally be treated medically by mineralocorticoid receptor antagonists.
Journal ArticleDOI
Increased Diagnosis of Primary Aldosteronism, Including Surgically Correctable Forms, in Centers from Five Continents
Paolo Mulatero,Michael Stowasser,Keh Chuan Loh,Carlos E. Fardella,Richard D. Gordon,Lorena Mosso,Celso E. Gomez-Sanchez,Franco Veglio,William F. Young +8 more
TL;DR: The wide use of the ARR as a screening test in hypertensive patients led to a marked increase in the detection rate of primary aldosteronism, which was previously believed to account for less than 1% of hypertensives.
Journal ArticleDOI
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort
Tracy Ann Williams,Tracy Ann Williams,Jacques W.M. Lenders,Jacques W.M. Lenders,Paolo Mulatero,Jacopo Burrello,Marietta Rottenkolber,Christian Adolf,Fumitoshi Satoh,Laurence Amar,Marcus Quinkler,Jaap Deinum,Felix Beuschlein,Kanako Kiriyama Kitamoto,Uyen Thi Phuong Pham,Ryo Morimoto,Hironobu Umakoshi,Aleksander Prejbisz,Tomaz Kocjan,Mitsuhide Naruse,Michael Stowasser,Tetsuo Nishikawa,William F. Young,Celso E. Gomez-Sanchez,John W. Funder,Martin Reincke +25 more
TL;DR: Consensus was reached for criteria for six outcomes based on blood pressure, use of antihypertensive drugs, plasma potassium and aldosterone concentrations, and plasma renin concentrations or activities based on clinical and biochemical outcomes.
Journal ArticleDOI
High incidence of primary aldosteronism in 199 patients referred with hypertension.
TL;DR: This study sought to assess the incidence of primary aldosteronism in 199 hypertensives who were normokalaemic and in whom the question of primaryAldoster onism had never been raised.